Technical Analysis for ZYME - Zymeworks Inc.

Grade Last Price % Change Price Change
grade D 15.25 -1.80% -0.28
ZYME closed down 1.8 percent on Tuesday, March 19, 2019, on 84 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ZYME trend table...

Date Alert Name Type % Chg
Mar 19 50 DMA Resistance Bearish 0.00%
Mar 19 Fell Below 20 DMA Bearish 0.00%
Mar 19 MACD Bearish Signal Line Cross Bearish 0.00%
Mar 19 Outside Day Range Expansion 0.00%
Mar 18 50 DMA Resistance Bearish -1.80%
Mar 18 Crossed Above 20 DMA Bullish -1.80%
Mar 15 Fell Below 20 DMA Bearish -0.52%
Mar 15 Fell Below 50 DMA Bearish -0.52%
Mar 14 Earnings Movers Other -3.17%
Mar 14 Upper Bollinger Band Touch Strength -3.17%

Older signals for ZYME ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Zymeworks Inc is a Canada-based clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of multifunctional biotherapeutics. The Company's ZymeCAD platform is for protein modeling and structure-guided protein engineering. The Company's platforms include Azymetric Platform, AlbuCORE Platform, EFECT Platform and Zymelink Conjugation Platform + Cytotoxins. The Company's lead product candidate, ZW25, is a bispecific antibody, which is being evaluated in an adaptive Phase I clinical trial. Its ZW33 is a bi-specific antibody that delivers a cytotoxic payload to cancers cells by binding to different epitopes (bi-paratopic targeting) of the overexpressed HER2 protein. It focuses on developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. It analyzes protein characteristics to develop the scope of protein engineering to tackle biological systems.
Medicine Biopharmaceutical Medical Specialties Immunology Cancers Immune System Monoclonal Antibodies Cancer Immunotherapy Antibody Sutro Biopharma Glycoproteins Protein Engineering
Is ZYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.0
52 Week Low 10.37
Average Volume 122,915
200-Day Moving Average 14.521
50-Day Moving Average 15.5922
20-Day Moving Average 15.4095
10-Day Moving Average 15.789
Average True Range 0.7658
ADX 13.83
+DI 18.3649
-DI 23.2432
Chandelier Exit (Long, 3 ATRs ) 15.0026
Chandelier Exit (Short, 3 ATRs ) 16.3474
Upper Bollinger Band 16.7106
Lower Bollinger Band 14.1084
Percent B (%b) 0.44
BandWidth 16.886985
MACD Line 0.1145
MACD Signal Line 0.1335
MACD Histogram -0.0191
Fundamentals Value
Market Cap 386.43 Million
Num Shares 25.3 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -4.33
Price-to-Sales 35.32
Price-to-Book 2.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.90
Resistance 3 (R3) 16.97 16.48 16.62
Resistance 2 (R2) 16.48 16.06 16.45 16.53
Resistance 1 (R1) 15.87 15.80 15.63 15.80 16.44
Pivot Point 15.38 15.38 15.26 15.35 15.38
Support 1 (S1) 14.77 14.96 14.53 14.70 14.06
Support 2 (S2) 14.28 14.70 14.25 13.97
Support 3 (S3) 13.67 14.28 13.88
Support 4 (S4) 13.60